Company profile
DB · companies + sec_company_profileBio-Techne Corporation (TECH) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolTECH
- Legal nameBio-Techne Corporation
- SectorHealthcare
- IndustryBiotechnology
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- CIK0000842023
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$8.61B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG000C15114
- CountryUS
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Kim Kelderman | Chief Executive Officer, President & Director | $2.29M | 1968 | — |
| James T. Hippel | Executive Vice President of Finance & Chief Financial Officer | $1.67M | 1971 | — |
| William A. Geist | President of Protein Sciences Segment | $1.34M | 1969 | — |
| Shane Bohnen | Senior Vice President, General Counsel, Corporate Secretary & Chief Sustainability Officer | $835.66K | 1975 | — |
| Gary J. Latham | Vice President & Chief Technology Officer | — | — | — |
| David Clair | Vice President of Investor Relations & Corporate Development | — | — | — |
| Gerry Andros | Vice President of Sales and Marketing | — | — | — |
| Martin Wirtz | Senior Vice President of Strategy & Corporate Development | — | — | — |